J O Prior
Overview
Explore the profile of J O Prior including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
198
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Champendal M, Ribeiro R, Muller H, Prior J, Sa Dos Reis C
Radiography (Lond)
. 2024 Jun;
30(4):1232-1239.
PMID: 38917681
Purpose: Artificial intelligence (AI) in positron emission tomography/computed tomography (PET/CT) can be used to improve image quality when it is useful to reduce the injected activity or the acquisition time....
2.
Delage J, Faivre-Chauvet A, Fierle J, Gnesin S, Schaefer N, Coukos G, et al.
EJNMMI Res
. 2020 Aug;
10(1):98.
PMID: 32804276
Purpose: TEM-1 (tumor endothelial marker-1) is a single-pass transmembrane cell surface glycoprotein expressed at high levels by tumor vasculature and malignant cells. We aimed to perform a preclinical investigation of...
3.
Doms J, Prior J, Peters S, Obeid M
Ann Oncol
. 2020 May;
31(9):1273-1275.
PMID: 32425357
No abstract available.
4.
Castelli J, Depeursinge A, Devillers A, Campillo-Gimenez B, Dicente Y, Prior J, et al.
Eur J Nucl Med Mol Imaging
. 2018 Aug;
46(3):638-649.
PMID: 30132054
Purpose: The aims of this multicentre retrospective study of locally advanced head and neck cancer (LAHNC) treated with definitive radiotherapy were to (1) identify positron emission tomography (PET)-F-fluorodeoxyglucose (F-FDG) parameters...
5.
Scher N, Castelli J, Depeursinge A, Bourhis J, Prior J, Herrera F, et al.
Cancer Radiother
. 2018 Apr;
22(3):229-235.
PMID: 29650390
Purpose: To identify predictive (F)-fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT)-based parameters for locoregional control, disease-free survival and overall survival, by testing different thresholds of metabolic tumor volume and...
6.
Castelli J, Depeursinge A, Ndoh V, Prior J, Ozsahin M, Devillers A, et al.
Eur J Cancer
. 2017 Feb;
75:222-230.
PMID: 28237868
Purpose: In the context of locally advanced oropharyngeal cancer (LAOC) treated with definitive radiotherapy (RT) (combined with chemotherapy or cetuximab), the aims of this study were: (1) to identify PET-FDG...
7.
Chilra P, Gnesin S, Allenbach G, Monteiro M, Prior J, Vieira L, et al.
EJNMMI Phys
. 2017 Feb;
4(1):10.
PMID: 28205113
Background: Our aim was to characterize the influence of time-of-flight (TOF) and point spread function (PSF) recovery corrections, as well as ordered subset expectation maximization (OSEM) reconstruction parameters, in Rb...
8.
Guinchard A, Ghazaleh N, Saenz M, Fornari E, Prior J, Maeder P, et al.
Hear Res
. 2016 Sep;
341:232-239.
PMID: 27663095
We studied possible brain changes with functional MRI (fMRI) and fluorodeoxyglucose positron emission tomography (FDG-PET) in a patient with a rare, high-intensity "objective tinnitus" (high-level SOAEs) in the left ear...
9.
Homulle H, Powolny F, Stegehuis P, Dijkstra J, Li D, Homicsko K, et al.
Biomed Opt Express
. 2016 May;
7(5):1797-814.
PMID: 27231622
In near infrared fluorescence-guided surgical oncology, it is challenging to distinguish healthy from cancerous tissue. One promising research avenue consists in the analysis of the exogenous fluorophores' lifetime, which are...
10.
Dunet V, Maeder P, Nicod-Lalonde M, Lhermitte B, Pollo C, Bloch J, et al.
Nuklearmedizin
. 2014 Apr;
53(4):155-61.
PMID: 24737132
Aim: MRI and PET with 18F-fluoro-ethyl-tyrosine (FET) have been increasingly used to evaluate patients with gliomas. Our purpose was to assess the additive value of MR spectroscopy (MRS), diffusion imaging...